Gender Differences in Parkinsonian Patients- a Swedish Register Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04713306|
Recruitment Status : Completed
First Posted : January 19, 2021
Last Update Posted : March 30, 2021
|Condition or disease|
Aim: To study differences between gender in diagnostic tools, pharmacological interventions, and self-reported symptoms in Parkinson´s Disease (PD).
Data were extracted from the Swedish Neuro Registers, one of the Swedish National Quality Registers. A mix of urban and rural parts of the country were chosen and data were divided by gender. Self-reported first experienced PD related symptom was used to define the starting point when processing the data. Zero to three years from this point was defined as early symptoms and over three years as late symptoms.
Differences between gender were seen in all chosen aspects, both diagnostically. Distinctions were also prominent in reported NonMotorSymptoms (NMS) profiles. These findings should be important to take into consideration for patients, professional staff, and caregivers in the daily work with gender mixed PD groups.
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||1217 participants|
|Target Follow-Up Duration:||14 Years|
|Official Title:||Gender Differences in Diagnostic Tools, Medication, Time to Medication and Non-motor Symptoms in Parkinsonian Patients- a Swedish Register Study|
|Actual Study Start Date :||January 1, 2006|
|Actual Primary Completion Date :||May 1, 2019|
|Actual Study Completion Date :||December 31, 2019|
Participants in the Swedish Neuro Register
Participants are patients with parkinsonian symptoms
- Differences between gender [ Time Frame: 2006-2020 ]investigations, medications,NonMotorSymptoms
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04713306
|Jönköping, Sweden, SE 551 85|
|Study Director:||Johan Lokk, PhD||Karolinska Institutet|